Novagant, Inc. Launches E-Commerce Website at GLAVAPE.com for New Medical Cannabis Products
01 Juillet 2014 - 2:00PM
Marketwired
Novagant, Inc. Launches E-Commerce Website at GLAVAPE.com for New
Medical Cannabis Products
DENVER, CO--(Marketwired -
July 01, 2014) - Novagant, Inc. (PINKSHEETS: NVGT) is pleased to announce that
it has launched its new E-Commerce portal website for its new
GLAVAPE™ product at www.glavape.com. The company previously
announced its new GLAVAPE™ Cannabidiol-rich hemp oil vape product
to enter into a potential $8.4 billion medical cannabis
industry.
The new website is dedicated solely to the
marketing and sale of GLAVAPE™ Vaporizer which is the most
commercially available source of legal Cannabidiol without need for
a medical cannabis prescription.
The www.glavape.com website allows for the purchase of the
GLAVAPE™ product by PayPal.
GLAVAPE™ is lab tested multiple times during the manufacturing
process, from seed to shelf. The Company tests for CBD
content, other cannabinoid content, yeast/mold/fungus, and bacteria
like E. coli to ensure safety and quality. GLAVAPE™ 0.3ml Pen
Tip is 100% natural and derived from the federally-legal industrial
hemp plant. The unique hemp cultivars, combined with
proprietary technologies, produce the highest quality CBD-rich hemp
oil in the world.
The GLAVAPE™ product can be
viewed: http://glavape.com/index.php?route=product/product&product_id=50
The GLAVAPE™ Pen is available in 0.3ml, 0.6ml, and 1.0ml and
sizes. The MSRP is to debut at only $33 USD for the 0.3ml Pen
Tip.
About Novagant,
Inc. Novagant, Inc. was incorporated in the state of Nevada
on February 23, 1987 under the name of Kendrex Systems,
Inc. The Company underwent several name changes, and
ultimately on November 26, 2013 changed its name to Novagant, Inc.
For more information about the Company, please visit
www.novagant.com.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact: Novagant, Inc. office@novagant.com
Novagant (CE) (USOTC:NVGT)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Novagant (CE) (USOTC:NVGT)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024